Impact of baseline cysts at the time of administration of gonadotropin-releasing hormone analog for in vitro fertilization

被引:0
|
作者
Zeyneloglu, HB
Isik, AZ
Kara, S
Senöz, S
Özcan, U
Gökmen, O
机构
[1] Dr ZT Burak Womens Hosp, Dept Reprod Endocrinol, Ankara, Turkey
[2] Dr ZT Burak Womens Hosp, IVF Unit, Ankara, Turkey
关键词
fertilization in vitro; ovarian cysts; gonadotropin-releasing hormone agonist; ovarian stimulation;
D O I
暂无
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective-To assess the effects of cysts developed prior to the commencement of luteal phase gonadotropin-releasing-hormone-agonist (GnRH-a) in IVF cycles. Design-Retrospective analysis. Setting-In vitro fertilization program in a tertiary hospital infertility clinic. Patients-Women stimulated for IVF-ET. All stimulations were down-regulated with GnRH-a commenced on day 21 in a long protocol before gonadotropin stimulation. Main Outcome Measure-Pregnancy rate. Results-Twenty-five of 121 cycles had cysts >15 mm (20.6%); these were classified as baseline (nonfunctional) (n = 12) or corpus luteum (n = 13) cysts. They had significantly longer suppression periods and lower peak estradiol levels, and used more gonadotropins during stimulation. Cysts had no impact on the number of oocytes collected or fertilization and pregnancy rates. Patients with baseline cysts had a greater duration of suppression and required more gonadotropin than those with corpus luteum cysts or those without cysts. The cycle outcomes were similar between the groups, but baseline cyst formation is likely to increase the cost of IVF. Conclusion-These findings suggest that baseline cyst formation causes longer suppression duration and greater gonadotropin utilization, although an impact on pregnancy rates is unlikely.
引用
收藏
页码:300 / 305
页数:6
相关论文
共 50 条
  • [31] ADVERSE NEUROLOGICAL SYMPTOMS AFTER GONADOTROPIN-RELEASING HORMONE ANALOG THERAPY FOR INVITRO FERTILIZATION CYCLES
    ASHKENAZI, J
    GOLDMAN, JA
    DICKER, D
    FELDBERG, D
    GOLDMAN, GA
    FERTILITY AND STERILITY, 1990, 53 (04) : 738 - 740
  • [32] COMPARISON OF DIFFERENT REGIMENS OF A GONADOTROPIN-RELEASING HORMONE ANALOG DURING OVARIAN STIMULATION FOR INVITRO FERTILIZATION
    BENADIVA, CA
    BLASCO, L
    TURECK, R
    MASTROIANNI, L
    FLICKINGER, GL
    FERTILITY AND STERILITY, 1990, 53 (03) : 479 - 485
  • [33] Optimizing assisted reproduction: impact of low-dose gonadotropin-releasing hormone agonist on in vitro fertilization outcome
    Lenton, E
    Mohamed, K
    FERTILITY AND STERILITY, 2005, 84 (06) : 1783 - 1785
  • [34] Introduction: Gonadotropin-releasing hormone agonist triggering of final follicular maturation for in vitro fertilization
    Casper, Robert F.
    FERTILITY AND STERILITY, 2015, 103 (04) : 865 - 866
  • [35] Gonadotropin-releasing hormone analog repairs reduced endometrial cell apoptosis in endometriosis in vitro
    Imai, A
    Takagi, A
    Tamaya, T
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2000, 182 (05) : 1142 - 1146
  • [36] Growth hormone and gonadotropin-releasing hormone analog therapy in haploinsufficiency of SHOX
    Ogata, T
    Onigata, K
    Hotsubo, T
    Matsuo, N
    Rappold, G
    ENDOCRINE JOURNAL, 2001, 48 (03) : 317 - 322
  • [37] GONADOTROPIN-RELEASING HORMONE
    VALENTA, LJ
    ZOLMAN, JC
    NEW ENGLAND JOURNAL OF MEDICINE, 1977, 297 (13): : 725 - 725
  • [38] GONADOTROPIN-RELEASING HORMONE
    YEN, SSC
    ANNUAL REVIEW OF MEDICINE, 1975, 26 : 403 - 417
  • [39] GONADOTROPIN-RELEASING HORMONE
    KRETSER, DMD
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1975, 5 (06): : 585 - 586
  • [40] Gonadotropin-releasing hormone
    Chow, Billy K. C.
    FEBS JOURNAL, 2008, 275 (22) : 5457 - 5457